11^th International Conference on
Dementia and Dementia Care

Born October 8, 1949, Mikkeli, Finland. 1979 PhD, University of Helsinki, Finland. 1980-1983 postdoctoral work with Brigid Hogan, Imperial Cancer Research Fund (ICRF), Mill Hill London, UK. 1984-1985 Assistant Professor, University of Medicine and Dentistry of New Jersey (UMDNJ), Rutgers Medical School, Piscataway, New Jersey, USA. 1985-1992 Associate Professor, Chief of Connective Tissue Research, UMDNJ, Robert Wood Johnson Medical School (formerly Rutgers Medical School), Piscataway, New Jersey, USA. 1992 - Professor, Wayne State University School of Medicine, Detroit, Michigan, USA. Published work on Matrix Biology,molecular cloning, and gene regulation. Present researchinterests in novel drug discovery methods, targeting astrocyte regulation of synaptic glutamate signaling in developmental and neuropsychiatric brain disorders.

Neuroscience| Alzheimer Dementia | Matrix Biology| Molecular Cloning

Dr.Sandeep Singh is a Neurobiologist with a strong background in Biochemistry and Biomedicine. He has dedicated more than 7 years to Neuroscience Research and used animal models system to investigate the therapeutic potential for Alzheimer's disease using synthetic as well as natural compounds in Drosophila model system. After obtaining his M.Sc. degree in Biotechnology, he completed his Ph.D. from Department of Biochemistry, Institute of Science, Banaras Hindu University then moved to the Department of Neurobiology, The University of Chicago, IL, USA and worked on the role of microbial immune responses in AD pathogenesis. Currently, he is the Founder President of a non-profit organization in India named Indian Science Education and Technology Foundation (ISET Foundation) and working in the field of Science and Technology Promotion (Neurobiology and Biotechnology Research Promotion). The last 7 years research work come up with a couple of nice publications to his credit in journals of international repute like (International Journal of Alzheimer's Disease, Neurotoxicity Research, Oxidative Medicine and Cellular Longevity, BBRC, Neurochemical Research, Neuroscience Letter, Current Drug Metabolism etc.) and 2 book chapter as mentioned in his CV. He is Member of the editorial board of several International neuroscience related journals. Also a member of several scientific societies like INDIAN ACADEMY OF NEUROSCIENCES, ALZHEIMER'S AND RELATED DISORDERS SOCIETY OF INDIA, American Academy of Neurology, International Society of Neurochemistry, Member of American Society of Neurochemistry.

Alzheimer's Disease

Simon Hooper is a co-founder of Health-Connected Ltd, the company behind RemindMeCare. He and Etienne Abrahams are on a mission to bring tech to the care process, courtesy of personal experience of the lack of person-centred care tech available during their own families care journeys. With deep experience of the start-up journey, from conception to crowd funding, incubators to accelerators and having worked for 4 years with care groups, those cared for in the community, hospital wards and care organisations, Simon's developed a broad knowledge of the care sector and its potential for tech adoption. At the core of everything they build is their belief that knowing the person and engaging in fun activities must be at the heart of the care process.View at: https://www.remindmecare.com/

Dementia and Elderly Care Technology

Solaphat Hemrungrojn , MD. has her proficiency in clinical dementia care , cognitive assessment and computerized cognitive training . She has built her experience after 20 years in dementia research , service , teaching both medical students and psychiatric residents in university hospital in Bangkok , Thailand. She and her team initiated cogntive fitness center in the university hospital with a tailor made individual cognitive training program for each elderly .

Neuro - Psychiatry | Dementia | Cognitive and Behavioral Neurology

Lucia Torres-Simon has her bachelor's in psychology. She has two master's degrees concerning neuropsychological evaluation and rehabilitation of brain/cognitive damage, and neuroimaging tools analysis and applications. She has passion in understanding impaired brain functioning and mechanisms of rehabilitation. She is developing deep knowledge about cerebrovascular disease in her doctoral studies, trying to shed light on the neurophysiological characterization of different subtypes of vascular cognitive impairment.

Vascular Dementia